MassMutual Private Wealth & Trust’s Mineralys Therapeutics MLYS Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio MLYS Stock Details MLYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.61K	Hold	319	–	–	﹤0.01%	1467
2026 Q1	$8.64K	Hold	319	–	–	﹤0.01%	1425
2025 Q4	$11.6K	Hold	319	–	–	﹤0.01%	1318
2025 Q3	$12.1K	Hold	319	–	–	﹤0.01%	1315
2025 Q2	$4.32K	Hold	319	–	–	﹤0.01%	1692
2025 Q1	$5.07K	Hold	319	–	–	﹤0.01%	1599
2024 Q4	$3.93K	Hold	319	–	–	﹤0.01%	1616
2024 Q3	$3.86K	Hold	319	–	–	﹤0.01%	1458
2024 Q2	$3.73K	Hold	319	–	–	﹤0.01%	1413
2024 Q1	$4.12K	Hold	319	–	–	﹤0.01%	1331
2023 Q4	$2.74K	Buy	+319	New	+$2.5K	﹤0.01%	1407

Other funds holding MLYS

Andera Partners Paris $206M AUM

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

ACM

ACT Capital Management Wayne, Pennsylvania $153M AUM

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

MassMutual Private Wealth & Trust's MLYS Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Mineralys Therapeutics (MLYS) position steady in Q2 2026 at 319 shares worth $8.61K. The position accounts for ﹤0.01% of the portfolio, ranked #1467.

MassMutual Private Wealth & Trust first reported a position in MLYS in Q4 2023 and has held it in 11 quarters since. The position peaked at $12.1K in Q3 2025. 32 funds tracked by Wall St. Rank hold MLYS as of Q2 2026.

MassMutual Private Wealth & Trust held 319 shares of Mineralys Therapeutics worth $8.61K as of Q2 2026.
MassMutual Private Wealth & Trust left its Mineralys Therapeutics share count unchanged in Q2 2026.
Mineralys Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1467 holding.
MassMutual Private Wealth & Trust first reported a position in Mineralys Therapeutics in Q4 2023 and has held it in 11 quarters since.
MassMutual Private Wealth & Trust's Mineralys Therapeutics position peaked at $12.1K in Q3 2025.
32 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.